Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

No need to panic over recent HRT and breast cancer study

April 25, 2024
Louise Newson
The recent news story linking HRT to an increased risk of breast cancer should give GPs more information to allow women to make an informed choice, says Women's Health consultant editor and menopausedoctor.co.uk GP Dr Louise Newson.

Lyme disease: diagnosis and treatment in general practice

May 2, 2024
Dr Sandra Pearson
It is important for GPs to be aware of the increasing problem of Lyme disease in the UK, which is no longer confined to remote rural areas.

NICE rejection leaves 40% of patients with idiopathic pulmonary fibrosis no treatment option, pharma Roche claims

May 2, 2024
Alison Bloomer
Patients suffering with idiopathic pulmonary fibrosis will have no early treatment options following NICE's refusal to grant a licence to pirfenidone (Esbriet), pharmaceutical Roche has announced.

Pharma Roche launches new idiopathic pulmonary fibrosis campaign

May 2, 2024
Alison Bloomer
Roche has teamed up with celebrity Myleene Klass to help launch a new campaign targeted at idiopathic pulmonary fibrosis (IPF).

Little reduction in prescribing of antipsychotics in dementia care homes, study finds

May 2, 2024
Alison Bloomer
There was no sustained reduction in the prescribing of antipsychotic drugs to people with dementia living in care homes, despite the government's 2009 National Dementia Strategy (NDS) recommending that their use be reviewed due to potential serious side effects, a study has found.

Smoking rates at their lowest ever

May 2, 2024
Rob Mair
Public Health England have announced that the smoking rate in England has also fallen to below 17% for the first time. The biggest decreases in smoking over the last four years can be seen in the South West (18.7% to 15.5%), the North East (22% to 18.7%) and Yorkshire and Humber (21.9% to 18.6%).

ESC endorses new plan for noncommunicable diseases

May 2, 2024
Alison Bloomer
The European Society of Cardiology (ESC) has welcomed and endorsed the new Action Plan for the prevention and control of noncommunicable diseases (NCDs) in the World Health Organization (WHO) European Region adopted by WHO's Regional Committee for Europe.

Premature ovarian insufficiency in primary care

May 2, 2024
Louise Newson
Premature ovarian insufficiency is frequently under diagnosed and poorly managed, with many health professionals unaware of the condition. Menopausal expert Dr Louise Newson looks at how patients living with condition can be cared for in general practice

Implications of the joint European cardiovascular disease prevention guidelines

May 2, 2024
Dr John Cannon
In May, the European Society of Cardiology issued new guidelines to prevent heart disease and improve management of patients. Dr John Cannon looks at the implications for primary care

Campaign to improve healthcare through better dialogue launched

October 6, 2022
admin
A campaign has been launched to improve the way health professionals talk to their patients.

New tool to help health professionals improve eczema management launched

October 6, 2022
admin
A new tool to help primary and secondary healthcare professionals improve eczema management for patients has been launched.

New website launched to help GPs feel confident in managing the menopause

November 25, 2022
Rob Mair
A new website has been launched to help GPs better understand the menopause with the aim of making them more confident in managing the condition in their patients.

Children and teenagers could benefit from new asthma therapy

October 6, 2022
admin
Children aged 6-17 could benefit from tiotropium Respimat if the drug is added to maintenance asthma therapy, according to findings from a Phase 3 clinical trial.

New research has shown that doctors are frequently inaccurate when predicting how long those living with terminal illnesses will survive.

October 6, 2022
admin
Researchers at the Marie Curie Palliative Care Research Department at UCL combined the results of previous studies, reviewing 4,642 records of clinicians' predictions regarding survival of patients approaching the ends of their lives. The study revealed wide variation in errors, ranging from an underestimate of 86 days to an overestimate of 93 days.

Scottish Medicines Consortium recommends new schizophrenia treatment

October 6, 2022
admin
The Scottish Medicines Consortium (SMC) has recommended the use of paliperidone palmitate 3-monthly injection (Trevicta) for use in NHS Scotland without restriction for the maintenance treatment of schizophrenia.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy